ALYMSYS vs VINORELBINE TARTRATE

Independent side-by-side comparison.

Rated against independent regulatory sources·Last updated October 7, 2026·How we rate

Possible drug interaction. ALYMSYS and VINORELBINE TARTRATE are different prescription medicines. Combining or switching between them can cause interactions — talk to a pharmacist or prescriber before making changes. This page is not medical advice.

Attribute	ALYMSYS	VINORELBINE TARTRATE
Rating	72/100	72/100
Pharmacy pays	—	—
Type	RX	RX
Active ingredient	BEVACIZUMAB-MALY	VINORELBINE TARTRATE
Manufacturer	Amneal	Rising
Dosage forms	Injectable	Injectable
Drug class	—	Vinca Alkaloid
Boxed warning	None	None
Treats	Non-Small-Cell Lung Carcinoma, Uterine Cervical Neoplasms, Fallopian Tube Neoplasms	Breast Neoplasms, Non-Small-Cell Lung Carcinoma, Hodgkin Disease

alymsys vinorelbine tartrate

Rating

72/100

Pharmacy pays

—

Type

Active ingredient

BEVACIZUMAB-MALY

VINORELBINE TARTRATE

Manufacturer

Amneal

Rising

Dosage forms

Injectable

Drug class

—

Vinca Alkaloid

Boxed warning

None

Treats

Non-Small-Cell Lung Carcinoma, Uterine Cervical Neoplasms, Fallopian Tube Neoplasms

Breast Neoplasms, Non-Small-Cell Lung Carcinoma, Hodgkin Disease

Frequently asked questions

Which is better-rated, Alymsys or Vinorelbine Tartrate?

Alymsys and Vinorelbine Tartrate are tied at 3.6 out of 5 by our independent rating.

What is the difference between Alymsys and Vinorelbine Tartrate?

Alymsys contains Bevacizumab-Maly, while Vinorelbine Tartrate contains Vinorelbine Tartrate — they have different active ingredients.

Ratings are based on FDA regulatory (recall-safety) data. This comparison is for general reference only — not medical advice. Always consult a licensed professional before choosing or switching a medication.